Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis
Journal of the Science of Food and Agriculture · 2024-02 · 104 (3) · 1702-1712
DOI: 10.1002/jsfa.13057 ↗At a glance
Journal article in Journal of the Science of Food and Agriculture, published online on 2023-11-22. Written by Chunhong Liu and 8 co-authors. Institution: School of Chemical Engineering and Chemistry, Harbin Institute of Technology, Harbin, China. Major MEDLINE topics: Colitis, Ulcerative, Limosilactobacillus fermentum, Gastrointestinal Microbiome, Colitis. Cited 31 times so far (Crossref); 66 references. Funded by: Natural Science Foundation of Sichuan Province.
Abstract (original language)
BACKGROUND Paraprobiotics and postbiotics have shown potential in the treatment of ulcerative colitis (UC). However, their in vivo application is still in its infancy and their mechanisms of action are not well understood. RESULTS Here, we investigated the mitigation effects of Limosilactobacillus fermentum HF06‐derived paraprobiotic (6‐PA) and postbiotic (6‐PS) on dextran sulfate sodium induced UC and the potential mechanisms. Results indicated that the administration of 6‐PA and 6‐PS resulted in the inhibition of weight loss and colon shortening in mice with UC. Furthermore, they led to a significant reduction in both fecal moisture content and the levels of proinflammatory cytokines and oxidative stress in the intestine of the mice. 6‐PA and 6‐PS treatment strengthened the intestinal mucosal barrier by dramatically upregulating the levels of zonula occludens‐1 and occludin proteins. In addition, 6‐PA and 6‐PS restored intestinal dysbiosis by regulating abundances of certain bacteria, such as Bifidobacterium , Faecalibaculum , Muribaculaceae, Corynebacterium , Escherichia‐Shigella and Clostridium_sensu_stricto_1 , and regulated the level of short‐chain fatty acids. CONCLUSION These findings illustrated for the first time that L. fermentum HF06‐derived paraprobiotic and postbiotic enhanced the intestinal barrier function, and restored gut microbiota alterations. © 2023 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Chemical Engineering and Chemistry, Harbin Institute of Technology, Harbin, China.
- Dairy Nutrition and Function, Key Laboratory of Sichuan Province, New Hope Dairy Company Limited, Chengdu, China.
- Jiangsu HOWYOU Biotechnology Co. Ltd, Qidong, China.
ORCID profiles: Chunhong Liu
Funding
- Natural Science Foundation of Sichuan Province
Cite
APA
Liu, C., Qi, X., Li, D., Zhao, L., Li, Q., Mao, K., Shen, G., Ma, Y., & Wang, R. (2024). Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis. Journal of the Science of Food and Agriculture, 104(3), 1702-1712. https://doi.org/10.1002/jsfa.13057
Vancouver
Liu C, Qi X, Li D, Zhao L, Li Q, Mao K, et al. Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis. Journal of the Science of Food and Agriculture. 2024;104(3):1702-1712. doi:10.1002/jsfa.13057
BibTeX
@article{Liu2024,
author = {Liu, Chunhong and Qi, Xiaofen and Li, Dan and Zhao, Le and Li, Qiming and Mao, Kaidong and Shen, Guiqi and Ma, Ying and Wang, Rongchun},
title = {Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
volume = {104},
number = {3},
pages = {1702--1712},
doi = {10.1002/jsfa.13057}
}
EUVIMED